Autolus Therapeutics plc ADR (AUTL) Implied Volatility Current

Tracking AUTL implied volatility helps you identify when options premiums on Autolus Therapeutics plc ADR are historically cheap or expensive, and where the best trades are hiding. Autolus Therapeutics plc ADR implied volatility reflects the market's expectation of future price movement: when AUTL IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Autolus Therapeutics plc ADR's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For AUTL, tracking metrics like AUTL IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on AUTL signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma.

It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where AUTL implied volatility sits today versus where it has been. Our scanner ranks Autolus Therapeutics plc ADR implied volatility against its historical range, surfaces extremes in AUTL IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Autolus Therapeutics plc ADR IV is rich or cheap — measure it, then act on it.